Orexin B, human hexylammonium salt 274 μM for LMP2 and

274 μM for LMP2 and LMP7

Mice treated with Lerociclib elicits 8% tumor regression after 21 days of treatment while control animals have a 577% increase in tumor burden over the same treatment period

Orally administered cilomilast dose-dependently inhibits production of interleukin-4

Formula: C43H65N9O9

and that this is a synergistic effect

Orexin B, human hexylammonium salt 274 μM for LMP2 andOrexin B, human is an endogenous agonist at Orexin receptor with Kis of 420 and 36 nM for OX1 and OX2, respectively. Product information CAS Number: 205640 91 1 Molecular Weight: 2899. 34 Formula: C123H212N44O35S Chemical Name: (2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 {2 [(2S) 2 [(2S) 2 (2 {[(2S) 1 [(2S) 1 {2 [(2S) 2 [(2S) 2 amino 5 carbamimidamidopentanamido] 3 hydroxypropanamido]acetyl}pyrrolidine 2 carbonyl]pyrrolidin 2